Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1963 1
1964 5
1975 3
1976 1
1977 4
1978 5
1979 8
1980 18
1981 12
1982 25
1983 34
1984 38
1985 56
1986 60
1987 51
1988 78
1989 82
1990 86
1991 70
1992 86
1993 80
1994 114
1995 74
1996 108
1997 87
1998 118
1999 101
2000 125
2001 126
2002 176
2003 197
2004 201
2005 262
2006 298
2007 317
2008 377
2009 451
2010 507
2011 626
2012 724
2013 791
2014 909
2015 986
2016 997
2017 1023
2018 1053
2019 1111
2020 1187
2021 1102
2022 967
2023 973
2024 312

Text availability

Article attribute

Article type

Publication date

Search Results

15,245 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for pr and breast neoplasms
Search for QDPR and Breast Neoplasms instead (1 results)
Alcohol and breast cancer.
Starek-Świechowicz B, Budziszewska B, Starek A. Starek-Świechowicz B, et al. Pharmacol Rep. 2023 Feb;75(1):69-84. doi: 10.1007/s43440-022-00426-4. Epub 2022 Oct 30. Pharmacol Rep. 2023. PMID: 36310188 Free PMC article. Review.
Breast cancer is one of the main causes of death in women worldwide. In women, breast cancer includes over half of all tumours caused by alcohol. ...
Breast cancer is one of the main causes of death in women worldwide. In women, breast cancer includes over half of all tumours
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets.
Liang Y, Zhang H, Song X, Yang Q. Liang Y, et al. Semin Cancer Biol. 2020 Feb;60:14-27. doi: 10.1016/j.semcancer.2019.08.012. Epub 2019 Aug 14. Semin Cancer Biol. 2020. PMID: 31421262 Review.
Over the past few years, intensive efforts have demonstrated that breast cancer exhibits metastatic heterogeneity with distinct metastatic precedence to various organs, giving rise to differences in prognoses and responses to therapy in breast cancer patients. Bone, …
Over the past few years, intensive efforts have demonstrated that breast cancer exhibits metastatic heterogeneity with distinct metas …
Endogenous estrogens-breast cancer and chemoprevention.
Starek-Świechowicz B, Budziszewska B, Starek A. Starek-Świechowicz B, et al. Pharmacol Rep. 2021 Dec;73(6):1497-1512. doi: 10.1007/s43440-021-00317-0. Epub 2021 Aug 30. Pharmacol Rep. 2021. PMID: 34462889 Free PMC article. Review.
Both estrogens and androgens play critical roles in the initiation and development of breast cancer. Estrogens influence normal physiological growth, proliferation, and differentiation of breast tissues, as well as the development and progression of breast ma …
Both estrogens and androgens play critical roles in the initiation and development of breast cancer. Estrogens influence normal physi …
Estrogen and progesterone receptors in breast cancer.
Yip CH, Rhodes A. Yip CH, et al. Future Oncol. 2014 Nov;10(14):2293-301. doi: 10.2217/fon.14.110. Future Oncol. 2014. PMID: 25471040 Review.
Breast cancer is the most common cancer in women worldwide. The majority of breast cancers show overexpression of estrogen receptors (ERs) and progesterone receptors (PRs). ...In recent guidelines, the recommended definition of ER and PR positivity is 1% or m
Breast cancer is the most common cancer in women worldwide. The majority of breast cancers show overexpression of estrogen rec
The Role of Progesterone Receptors in Breast Cancer.
Li Z, Wei H, Li S, Wu P, Mao X. Li Z, et al. Drug Des Devel Ther. 2022 Jan 26;16:305-314. doi: 10.2147/DDDT.S336643. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35115765 Free PMC article. Review.
PR is also a valuable prognostic biomarker in breast cancer, especially in hormone-positive breast cancer. ...In the following review, we present the role of PR in breast cancer, including the genomic characteristics and pathways in breast
PR is also a valuable prognostic biomarker in breast cancer, especially in hormone-positive breast cancer. ...In the fo
Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X, Liu C, Yao J, Wan H, Wan G, Li Y, Chen N. Zeng X, et al. Pharmacol Res. 2021 Jan;163:105320. doi: 10.1016/j.phrs.2020.105320. Epub 2020 Dec 1. Pharmacol Res. 2021. PMID: 33271295 Review.
To date, the understanding of breast cancer has been extended by advances in CSC biology, providing more accurate prognostic and predictive information upon diagnosis. Recent improvements have enhanced the prospect of targeting breast cancer stem cells (BCSCs), whic …
To date, the understanding of breast cancer has been extended by advances in CSC biology, providing more accurate prognostic and pred …
New and Important Changes in the TNM Staging System for Breast Cancer.
Hortobagyi GN, Edge SB, Giuliano A. Hortobagyi GN, et al. Am Soc Clin Oncol Educ Book. 2018 May 23;38:457-467. doi: 10.1200/EDBK_201313. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231399 Free article. Review.
Many of the chapters of the eighth edition of the AJCC TNM staging system integrated biomarkers with anatomic definitions. The Breast Chapter added estrogen receptor (ER) and progesterone receptor (PR) expression, HER2 expression, and/or amplification and histologic …
Many of the chapters of the eighth edition of the AJCC TNM staging system integrated biomarkers with anatomic definitions. The Breast
Differences in Breast Cancer Survival by Molecular Subtypes in the United States.
Howlader N, Cronin KA, Kurian AW, Andridge R. Howlader N, et al. Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):619-626. doi: 10.1158/1055-9965.EPI-17-0627. Epub 2018 Mar 28. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29593010
Background: Although incidence rates of breast cancer molecular subtypes are well documented, effects of molecular subtypes on breast cancer-specific survival using the largest population coverage to date are unknown in the U.S. ...Breast cancer molecular sub …
Background: Although incidence rates of breast cancer molecular subtypes are well documented, effects of molecular subtypes on bre
Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Zhang M, Chen H, Wang M, Bai F, Wu K. Zhang M, et al. Biosci Rep. 2020 Feb 28;40(2):BSR20193286. doi: 10.1042/BSR20193286. Biosci Rep. 2020. PMID: 32043519 Free PMC article.
The relationship between COL10A1 expression level and clinical indicators including prognostic data in breast cancer were analyzed by the Kaplan-Meier Plotter, PrognoScan, and Breast Cancer Gene-Expression Miner (bc-GenExMiner) databases. RESULTS: COL10A1 was up-reg …
The relationship between COL10A1 expression level and clinical indicators including prognostic data in breast cancer were analyzed by …
Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Chang VC, Rhee J, Berndt SI, Moore SC, Freedman ND, Jones RR, Silverman DT, Gierach GL, Hofmann JN, Purdue MP. Chang VC, et al. Int J Cancer. 2023 Aug 15;153(4):775-782. doi: 10.1002/ijc.34487. Epub 2023 Mar 7. Int J Cancer. 2023. PMID: 36843273
We used multivariable conditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between each PFAS and breast cancer risk, overall, by estrogen receptor (ER) or progesterone receptor (PR) status, and by joint …
We used multivariable conditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association b …
15,245 results
You have reached the last available page of results. Please see the User Guide for more information.